Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000899243-23-016417

Director acquired 13,671 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bruhn Suzanne Louise Director 2023-06-21 Grant or award +13,671 19,623 D
Derivatives
Bruhn Suzanne Louise Director 2023-06-21 Grant or award · Stock Option (Right to Buy) +19,203 27,267 D
Loading xslF345X04/doc4.xml…